USPTO serial 87245461
INTRACEUTICS
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- MARTIN, CHRISTINE C
- Law office
- TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with INTRACEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Quebec City, Quebec, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Leonard
MICHAEL J. LEONARD FOX ROTHSCHILD LLP997 LENOX DRIVE, BLDG. 3LAWRENCEVILLE, NJ 08648-2311UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the prevention and treatment of menopause, sexual dysfunction, vaginal atrophy, decreased libido, gynaecological disorders affecting menstruation, premenstrual syndrome, sterility, menstrual syndromes, dysmenorrhea, infertility, genital tract infections, pelvic inflammatory diseases, endometriosis, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities; pharmaceutical preparations and substances for the prevention and treatment of menopausal problems, neoplasia, breast neoplasm, breast cancer, mastopathy, mastodynia, breast pain; pharmaceutical preparations and substances for the prevention and treatment of the endocrine system; pharmaceutical preparations and substances for the prevention and treatment of oily skin, acne, male baldness; pharmaceutical preparations and substances for the prevention and treatment of prostate cancer and benign prostate enlargement; pharmaceutical preparations and substances for the prevention and treatment of obesity, high cholesterol, diabetes, loss of muscle mass and strength, bone loss | ACTIVE | — |
| 035 | Wholesale distributorship of pharmaceuticals for others | ACTIVE | — |
| 040 | Custom manufacture of pharmaceutical products to the order and specification of others | ACTIVE | — |
| 041 | Pharmaceutical educational services and patient educational services, namely, providing classes, workshops and seminars in the fields of treatment and prevention of cancer and endocrine-related disorders and diseases | ACTIVE | — |
| 042 | Research and development in the field of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; medical laboratory services; laboratory research in the fields of treatment and prevention of cancer and endocrine-related disorders and diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Endoceutics, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named INTRACEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 3, 2017 | MAB1 | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | — |
| Jul 3, 2017 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Jun 30, 2017 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Mar 6, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 28, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 30, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 25, 2016 | NWAP | NEW APPLICATION ENTERED | — |